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Pulmonary nodular lymphoid hyperplasia is a reactive lymphoproliferative disease. It is very rare, which 
means that many aspects of the disease are unknown or have not been proven. Pulmonary nodular lymphoid 
hyperplasia can be symptomatic or asymptomatic, progressive or not, and solitary or multiple, and a surgical 
approach is the current treatment of choice. We present a case of pulmonary nodular lymphoid hyperplasia 
that was visualized as multiple ground glass opacities on a computed tomography (CT) scan, and observed 
for 1 year because the patient was pregnant. Over this period, the number and extent of the opacities pro-
gressed, but no symptoms were reported. A surgical biopsy was done and some remaining lesions regressed 
on follow-up CT scans, while others progressed, without any appearance of symptoms.
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Case report
A 33-year-old woman was referred from a local 
hospital with incidental abnormal chest computed to-
mography (CT) scan findings in 2014. She had no re-
markable symptoms, and was healthy, without any 
prior clinical history except for having been diag-
nosed with a benign thyroid nodule.
The initial chest CT scan performed in June 2014 
revealed several bilateral ground glass opacities 
(GGOs) measuring up to 1 cm and 1 right apical le-
sion measuring 1.2 cm, which was an aggregated cal-
cified granuloma with fibrotic changes (Fig. 1A, B). 
The GGOs were multifocal and showed a nodular pat-
tern, suggesting that they were likely to be chronic 
lesions, and the initially proposed differential diag-
nosis included atypical adenomatous hyperplasia 
(AAH), adenocarcinoma in situ, or organizing pneu-
monia. The calcified granuloma in the right apex was 
thought to be most likely a post-inflammatory change.
A follow-up chest CT scan was done 3 months lat-
er, and no interval change was found. The complete 
blood count and routine laboratory results were 
within the normal range, except for the serum total 
immunoglobulin E level, which was slightly elevated 
(115 kU/L). A video-assisted thoracic surgery biopsy 
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Fig. 1. Initial chest computed to-
mography scan in 2014. (A) The 
ground glass opacities was 1.0 cm 
at right upper lobe apex (arrow). 
(B) Calcified granuloma in the right 
apex of the lung (arrow). (C, D) 
Final chest computed tomography 
scan before the surgical biopsy in 
September 2015, showing an in-
creased number and extent of mul-
tifocal peribronchovascular distrib-
uted nodular ground glass opacities 
in both lungs (arrows).
was thought to be the most appropriate choice for 
evaluating the GGO nodules, but before the biopsy 
was performed, it was found that the patient had an 
intrauterine pregnancy and was 3 weeks pregnant. 
The surgical biopsy was postponed until September 
2015, after she gave birth.
A year later, another follow-up CT scan was done 
in August 2015, finding an increased number and ex-
tent of multifocal peribronchovascular GGOs in both 
lungs compared with the previous study (Fig. 1C, D). 
Adenocarcinoma with multiple AAH seemed to be the 
most likely diagnosis, followed by mucosa-associated 
lymphoid tissue (MALT) lymphoma.
A video-assisted thoracic surgical biopsy was done 
in September 2015. After wedge resection of left up-
per lobe using 2 endostaplers, 2 nodules were pal-
pable in the specimen. The specimen consisted of re-
sected lung tissue, measuring 6×4×1.7 cm. The cut 
sections revealed 2 ill-defined whitish solid nodules, 
measuring 1.3×1.3 cm and 0.7×0.5 cm, respectively.
She was discharged 2 days after surgery without 
any complications, and the pathologic results were 
received 1 week later. The histopathologic examina-
tion showed follicular lymphoid hyperplasia with in-
terfollicular lymphoplasmacytosis, consistent with nod-
ular lymphoid hyperplasia (Fig. 2). The immunohisto-
chemical results showed CD3 and CD20 positivity, fo-
cal positivity of the kappa and lambda light chains, 
and Bcl-2 negativity.
The patient has been followed up with annual 
chest CT scans subsequently. A follow-up chest CT in 
June 2016 showed that some GGOs had progressed, 
while others had regressed spontaneously (Fig. 3A, 
B). She has visited our outpatient clinic every 3 
months, and has shown no symptoms for the past 22 
months.
Discussion
Pulmonary nodular lymphoid hyperplasia (PNLH) 
is a reactive lymphoproliferative disease. It was first 
described in 1983 by Kradin and Mark [1] and only 
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Fig. 2. (A) Diffuse nodular effacement of the lung parenchymal structure by lymphoid infiltration (H&E, ×100). (B) Aggregation of poly-
morphic lymphocytes and plasma (H&E, ×400). (C) Polytypic pattern of kappa light chain expression (dark blue). (D) Polytypic pattern of 
lambda light chain expression (dark blue).
Fig. 3. Follow-up computed tomog-
raphy scan obtained 1 year after 
the surgical biopsy, in September 
2016. (A) The ground glass opac-
ities in the right lower lobe had be-
come smaller than observed in the 
computed tomography scan from 
September 2015 (arrow). (B) The 
solid portion of some lesions pro-
gressed and new lesions emerged 
(arrows).
dozens of cases have been reported since then. 
Before Abbondanzo et al. [2] reviewed 14 cases of 
PNLH, proposed it as a disease entity, and suggested 
a treatment strategy, it was often referred to as 
pseudolymphoma, and many authors believed that it 
corresponded to MALT lymphoma [3]. PNLH has no 
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disease-specific symptoms, characteristics, or radio-
logic findings, and its prognosis has also been found 
to vary.
At first, PNLH was suggested as a term to describe 
the presence of 1 or more nodules or infiltrates com-
posed of reactive lymphoid cells. It is now diagnosed 
histologically or immunohistochemically. Histologically, 
PNLH is composed of well-defined lymphoid tissue 
masses with numerous reactive germinal centers, in-
terfollicular lymphocytes, and plasma cells. Immuno-
histochemical findings show a mixture of T and B 
cells with germinal centers expressing CD20 antigens 
and interfollicular lymphocytes expressing CD3, CD43, 
and CD5 [4]. Focal positivity of the lambda and kap-
pa light chains is also found in PNLH. This case 
showed the characteristic features of follicular lym-
phoid hyperplasia with interfollicular lymphoplasma-
cytosis, and immunostaining showed CD3 and CD20 
positivity with focal positivity of the lambda and 
kappa light chains.
This case presented 2 characteristic features. One 
was the radiologic feature of multiple and bilateral 
GGOs, because of which the differential diagnosis in-
cluded malignancy. The differential diagnosis in-
cluded adenocarcinoma (minimally invasive or in-
vasive) with multiple AAH, multifocal lymphoma 
(MALT lymphoma), and multiple focal fibrosis. The 
GGOs were multiple and could not be completely re-
sected, so only a surgical biopsy was done to con-
firm the diagnosis and to determine the proper 
course of treatment. Several cases of multiple GGOs 
in PNLH have been found since Kajiwara et al. [5] 
first reported this feature in 2005. Most of the pre-
viously reported cases of PNLH have been solitary 
pulmonary nodules.
Second, the patient did not receive any treatment 
for PNLH for nearly a year because of her pregnancy, 
and only 2 lesions were resected for the purpose of 
pathologic confirmation. Therefore, this case provides 
useful information on the natural course of PNLH. 
Until surgery, the number and extent of the lesions 
on radiography progressed without symptom 
aggravation. Future long-term follow-up of this pa-
tient might yield more insights into the long-term 
natural course of the remaining lesions and the prog-
nosis of this disease.
The treatment of choice for PNLH has been surgi-
cal resection since Abbondanzo et al. [2] reported 14 
cases of PNLH in 2000. Most of the previously de-
scribed cases had single pulmonary nodules, and ev-
ery patient received complete surgical resection, with 
no recurrence observed. However, in 2005, Kajiwara 
et al. [5] reported a case of PNLH with multiple 
GGOs; only a surgical biopsy was done and the re-
maining lesions spontaneously regressed during the 
follow-up period. Miyoshi et al. [6] reported a similar 
case of a 50-year-old male patient with small multi-
ple nodular lung lesions, in whom a surgical biopsy 
was performed and the remaining lesions regressed 
spontaneously after 6 years.
These 2 cases imply that surgical resection may 
not be the only answer for the treatment of PNLH. 
However, it is very difficult to decide whether to re-
move the nodule(s), because the clinicopathology of 
the disease is poorly understood. More information 
and cases should be gathered to understand why 
some patients show progression and others experi-
ence regression.
In our case, only a surgical biopsy was performed, 
and the patient has been followed up for 22 months 
so far. Some progression and regression have been 
found simultaneously in follow-up CT scans, but no 
symptoms have been reported. Long-term follow-up 
will clarify the natural course of the remaining le-
sions and yield further insights into the prognosis of 
PNLH.
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